Photodynamic Therapy For Onychomycosis
ConditionOnychomycosis of Toenail
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-100
SponsorThe University of Texas Health Science Center, Houston
About this trial
The purpose of this study is clinical and mycological clearance of onychomycosis using photodynamic therapy (PDT) with aminolevulinic acid (ALA) 10% gel at 6 months, 3 months, 9 months and 12 months
Eligibility criteria
Qualifiers
Clinical and mycological diagnosis [by potassium hydroxide (KOH) stain] of onychomycosis
Disqualifiers
Known or suspected allergies or sensitivities to any components of any of the study drugs
Patients with coagulation disorders
Known or suspected claustrophobia
Pregnancy during the treatment period
Trial design
Treatments tested in this trial
- ALA 10% gel
- PDT
- Urea
Treatment groups
5 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov